Intelligent Nanocellulose-Based Medical Implant Systems

Publication ID: 24-11857405_0008_PTD

Published: October 28, 2025

Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Nanocellulose-Based Medical Implant Systems,” Published Technical Disclosure No. 24-11857405_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857405_0008_PTD

This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,405.

Summary of the Inventive Concept

The present inventive concept integrates nanocellulose-based medical implants with cutting-edge technologies like AI, IoT, blockchain, and advanced materials to create novel, high-performance systems for bile duct repair and other medical applications.

Background and Problem Solved

The original patent for a medical implant based on nanocellulose addressed the critical issue of bile duct reconstruction in hepato-biliary surgery. However, the original invention had limitations in terms of implant customization, placement optimization, and post-operative monitoring. The new inventive concept overcomes these limitations by synergistically combining the nanocellulose-based implant with AI-powered surgical planning, IoT-enabled sensors, blockchain-based tracking, and advanced materials.

Detailed Description of the Inventive Concept

The inventive concept comprises a nanocellulose-based medical implant produced using a microbial cellulose tube, which is integrated with one or more of the following technologies: an AI-powered surgical planning module for optimizing implant placement; machine learning algorithms for generating customized implant designs based on patient-specific data; an IoT-enabled sensor for monitoring implant performance and detecting potential complications; a blockchain-based decentralized ledger for recording and verifying implant production, distribution, and usage; and a composite material incorporating the nanocellulose-based matrix with reinforcing materials like graphene, carbon nanotubes, or metal nanoparticles.

Novelty and Inventive Step

The new claims introduce a novel combination of the nanocellulose-based implant with distinct technologies, resulting in a synergistic system that provides improved performance, customization, and monitoring capabilities. The inventive step lies in the integration of these technologies to create a more powerful and effective system for bile duct repair and other medical applications.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different AI algorithms for surgical planning, varying types of IoT sensors for implant monitoring, or alternative blockchain platforms for tracking and verification. Additionally, the nanocellulose-based matrix could be combined with other reinforcing materials or used in conjunction with other medical implant technologies.

Potential Commercial Applications and Market

The intelligent nanocellulose-based medical implant systems have significant commercial potential in the medical device industry, particularly in the areas of hepato-biliary surgery, tissue engineering, and personalized medicine. The target market includes hospitals, research institutions, and medical device manufacturers seeking innovative solutions for complex medical procedures.

CPC Classifications

Section	Class	Group
A	A61	A61F2/04
A	A61	A61L31/005
A	A61	A61L31/10
A	A61	A61L31/146
A	A61	A61F2002/041
A	A61	A61L2400/12
A	A61	A61L2420/08
C	C08	C08L1/02

Section 103 Obviousness Analysis (PHOSITA)

▼

Field of Art

Medical device engineering, specifically biomaterials and implant technologies focusing on nanocellulose-based medical devices for tissue reconstruction, requiring expertise in materials science, biomedical engineering, and advanced manufacturing techniques

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or materials scientist with advanced degree, working knowledge of nanocellulose fabrication, medical implant design, and emerging digital health technologies, capable of integrating multiple technological domains

Obviousness Rationale

A PHOSITA would recognize that integrating digital technologies with the nanocellulose medical implant represents a predictable extension of existing medical device innovation, where monitoring, customization, and tracking capabilities are standard evolutionary improvements in biomedical engineering. The source patent's foundational nanocellulose tube technology provides a clear technical platform for incorporating advanced computational and sensing technologies. These variations represent logical combinations of known techniques within medical device design that would be apparent to a skilled practitioner seeking to enhance implant performance and patient outcomes.

Obvious Combinations & Variations

Source Patent Element

Microbial cellulose tube with specific structural layers for medical implant

PTD Variation

Adding IoT-enabled sensors for performance monitoring integrated into nanocellulose matrix

Obviousness Reasoning

Embedding sensors in medical implants is a known technique for real-time patient monitoring, representing a predictable technological enhancement with expected functional improvements

Source Patent Element

Method of producing tubular medical implant using template molding

PTD Variation

Using machine learning algorithms to generate patient-specific implant geometries

Obviousness Reasoning

Customizing medical devices through computational design is a standard practice in personalized medicine, representing an obvious application of known computational techniques

Source Patent Element

Nanocellulose tube with concentric layers

PTD Variation

Incorporating reinforcing materials like graphene or carbon nanotubes to enhance mechanical properties

Obviousness Reasoning

Material enhancement through nanocomposite strategies is a well-established approach in biomaterials engineering, representing a predictable optimization of structural performance

Source Patent Element

Medical implant for bile duct reconstruction

PTD Variation

Blockchain-based tracking system for implant production and distribution

Obviousness Reasoning

Implementing blockchain for medical device traceability is an emerging but obvious technological solution addressing regulatory and safety requirements

Source Patent Element

Tubular medical implant production method

PTD Variation

AI-powered surgical planning module for optimizing implant placement

Obviousness Reasoning

Computational surgical planning represents a logical technological progression in medical device design, leveraging known machine learning techniques to improve clinical outcomes

35 U.S.C. § 103 Summary: Based on US Patent 11857405's teachings of nanocellulose medical implants, the present publication demonstrates that a person of ordinary skill in the art would find the disclosed technological variations obvious, specifically the integration of digital technologies, computational design methods, and advanced material composites with established nanocellulose implant architectures, thereby rendering subsequent claims covering similar technological combinations anticipated and non-patentable under standard obviousness criteria.

Original Patent Information

Patent Number	US 11,857,405
Title	Medical implant based on nanocellulose
Assignee(s)	UNIVERSITÄTSKLINIKUM JENA